Last update :
Anti-arrhythmic   Amiodarone hydrochloride  
Capsule Oral solution
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Acrodarona Ecuador
Amidovin Turkey
Amiocar Argentina, Peru
Amiodar Italy
Amiodaron Germany, Norway, Sweden
Amiodarona Argentina, Chile, Colombia, Ecuador, Mexico, Peru
Amiodarone Australia, Canada, Great Britain, Iran, Italy, Luxembourg, New Zealand, United States of America
Amiohexal Germany
Amiokordin Hungary, Poland, Romania
Amiorit Venezuela
Ancoron Brazil
Angoron Greece
Asulblan Argentina
Atlansil Argentina, Brazil, Chile, Ecuador, Peru
Cardasol India
Cardichek India
Cardio Egypt
Cirtrent Mexico
Cordalin Turkey
Cordarex Germany
Cordarone Australia, Belgium, Chile, Colombia, Denmark, Ecuador, Finland, France, Great Britain, Hungary, Iceland, Ireland, Italy, Luxembourg, Malaysia, Mexico, Morocco, Netherlands, New Zealand, Norway, Poland, Portugal, Saudi Arabia, Sweden, Switzerland, Tunisia, Turkey, United Arab Emirates, United States of America
Duron India
Eudarona Venezuela
Eurythmic India
Farcodarone Egypt
Ronecard Egypt
Sedacoron Austria, Poland, Romania, Saudi Arabia, Tunisia
Sedacorone Iran
Trangorex Spain, Venezuela
Stability in solutions   Injection   Stability in solutions : Amiodarone hydrochloride     
Container Solvent Concentration Temperature Storage Duration of stability References
Glass NaCl 0,9% or Glucose 5% 2 mg/ml 25°C Protect from light
32 Day
Level of evidence A

Glass NaCl 0,9% or Glucose 5% 2 mg/ml 5°C Protect from light
32 Day
Level of evidence A

Glass Sodium chloride 0,9% 0,84 mg/ml 25°C Light
6 Hour
Level of evidence B

Glass Glucose 5% 0,6 mg/ml 22°C-24°C Not specified
5 Day

Polyolefine NaCl 0,9% or Glucose 5% 1,8 mg/ml 24°C Light
24 Hour
Level of evidence C

Polyolefine Glucose 5% 0,9 mg/ml 25°C Light
24 Hour
Level of evidence B

Polypropylen Syringe Glucose 5% 25 mg/ml 2-8°C Protect from light
28 Day
Level of evidence B+

  Mentions Légales